RxC International to Lead Gene Therapy Panel at NewYorkBIO Annual Conference May 11 – 12, 2016

MORRISTOWN, N.J.–(BUSINESS WIRE)– RxC
International today announced that it has been selected by NewYorkBIO,
New York State’s life science trade association, to lead a panel on gene
therapy at its annual conference in New York City, May 11 – 12, 2016.
The panel will be led by RxC International Senior Partner Richard
Tinsley.

“We are excited to bring a diverse group of thought leaders together to
explore the fast-emerging gene therapy segment of the life sciences
industry,” said Subbarao Jayanthi, managing partner of RxC International.

RxC International Senior Partner Richard Tinsley said, “Although there
are only four gene therapy products approved across the major developed
markets – North America, the EU, and Japan – there are nearly 1,000
active gene therapy programs in development across a wide range of
therapy areas and disease states. Gene therapy programs face a range of
unique R&D, commercialization, funding, legal and ethical issues. Our
panel will explore some of the hurdles faced by life science leaders
working with this promising therapeutic class.”

The RxC International gene therapy panel members will include:

• Sean Ainsworth, CEO, RetroSense
• Constance Bagley, Senior Research Scholar at Yale Law School,
  consultant, and author
• Jim Dentzer, Chief Financial and Chief Administrative Officer at Curis

“We are pleased to have RxC International’s participation at the
conference given its focus as an organization on this topic and the
growing interest across the industry in this therapy area,” said
NewYorkBIO Executive Director Nathan Tinker.

About New York Biotechnology Association, Inc.

New York Biotechnology Association, Inc. (NewYorkBIO) supports the
development and growth of New York State’s life science industry and
serves its members and the life science community by providing a network
for public policy, industry advocacy, and community development. For
over 25 years, NewYorkBIO and its 250+ member companies have been at the
forefront of developing, nurturing, and expanding New York’s life
science industry. For more information about NewYorkBIO and the
conference, see: www.newyorkbio.org.

About RxC International

RxC International is a premier life sciences management consulting firm.
The RxC team collaborates with clients to identify and develop growth
opportunities. RxC leverages consulting partners and advisers to combine
strategic and operational expertise to bring multiple perspectives to
every engagement. RxC has deep expertise in corporate strategy, new
product planning and commercial excellence.

RxC International clients include global pharmaceutical and
biotechnology companies as well as other specialty life sciences
companies such as vaccine, biosimilar, diagnostic, and medical device
companies. RxC has offices in New Jersey, Massachusetts, and California.
Additional information about RxC International can be found at www.rxcinternational.com.

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160426005597/en/